India healthcare
Affordable Sickle Cell Cure: India Aims for Rs 50 Lakh Treatment
India plans to offer a revolutionary cure for sickle cell disease at Rs 50 lakh, significantly lower than the Rs 20 crore cost abroad.
Leaked Cancer Drug: Counterfeit Keytruda Poses Risk to Patients
The counterfeit Keytruda drug crisis poses a significant threat to cancer patients in India, exposing them to scams and unregulated medications.
The Rs 12,000 Crore Race for GLP-1 Drugs: Impact on India’s Obesity Crisis
India is witnessing a surge in demand for GLP-1 drugs, potentially transforming obesity treatment while raising regulatory concerns.